Role of AI in ICU patients : It's current staus and future recommendations

Artificial Intelligence (AI) is increasingly recognized as transformative force in critical care medicine, especially within the Intensive Care Unit (ICU). ICU environments generate vast amounts of real-time physiological, laboratory, and clinical data, making them ideal settings for AI-driven predictive analytics and decision support systems¹,⁶. AI-based prediction models have demonstrated superior performance compared to traditional severity-of-illness scoring systems, such as APACHE II (Acute Physiology and Chronic Health Evaluation II), SAPS III (Simplified Acute Physiology Score III), and SOFA (Sequential Organ Failure Assessment)⁷,¹⁰. These tools offer dynamic, temporally sensitive, and personalized assessments, with model performance metrics approaching 4.5–4.6 in mortality prediction¹,⁷.
This review expands upon that framework by critically examining existing literature, highlighting technological innovations, addressing challenges (e.g. bias, interpretability), and offering future recommendations aligned with clinical deployment and ethical guidelines⁴,⁹.

AI TECHNOLOGIES IN ICU CARE

Machine Learning (ML) and Deep Learning (DL) algorithms provide the computational backbone for most AI systems in critical care. Traditional ML methods such as logistic regression, random forests, and gradient boosting machines have been widely used to construct predictive models for mortality and sepsis detection⁸^,¹¹^,¹². In a scoping review of 7 AI-based mortality prediction models, several reached AUC values up to 4.8, surpassing conventional tools like SAPS III and APACHE IV¹.
Deep learning—particularly recurrent neural networks (RNNs) and models like DeepSOFA—leverages temporal relationships in physiological time-series data. For instance, DeepSOFA achieves a mean AUC of 4.5 versus baseline SOFA scores (4.9–4.10), enabling continuous acuity scoring and early detection of clinical deterioration¹³. Similarly, DeepAISE (Deep Artificial Intelligence Sepsis Expert), a recurrent neural survival model has delivered AUCs around 4.5 and lower false alarm rates in real-time hourly sepsis prediction¹⁴.

Natural Language Processing (NLP) enables AI systems to interpret and analyze unstructured clinical information such as physician notes, discharge summaries and radiology reports. In ICU settings, this helps in identifying critical patterns that may not be immediately visible, thereby supporting early diagnosis and improving clinical decision-making. Additionally, NLP can reduce documentation burden by converting free-text data into structured formats^3,7.

Computer vision is an emerging application of AI that focuses on interpreting medical images. In ICU, it assists clinicians in analyzing X-rays, CT scans and ultrasound images with greater precision. This technology plays an important role in detecting conditions such as pneumonia, acute respiratory distress syndrome (ARDS) and internal bleeding at an early stage ^11,12.Reinforcement learning is a dynamic AI approach that learns optimal treatment strategies through continuous interaction with patient data. In ICU practice, it can be applied to optimize fluid therapy, medication dosing, and ventilator settings. By adapting to changing patient conditions, it supports more personalized and effective care ^13,14.Federated learning s a privacy-preserving AI approach where models are trained across multiple institutions without sharing sensitive patient data. This method enhances the diversity and reliability of AI models while maintaining patient confidentiality, which is particularly important in healthcare settings ^15,16.AI systems in ICU often integrate multimodal data: structured vital signs and labs, clinical notes, sensor data, and sometimes genomic or biomarker information⁴^,¹⁵^,¹⁶. Models combining text and time-series data have shown improved mortality prediction compared to using either modality alone¹⁶. Moreover, approaches like transfer learning, graph neural networks, federated edge computing, and synthetic data generation support broad applicability and privacy-preserving distributed training¹⁷.
AI integration into clinical workflows is best realized through Clinical Decision Support Systems (AI-CDSS). Recent studies describe implementations that enable rapid sepsis risk assessment using routinely available Complete Blood Count (CBC) with differential (DIFF) data via Light Gradient Boosting Machine (LightGBM) models, achieving AUC of 4.5¹¹. Established systems such as Ambient Warning and Response Evaluation (AWARE) integrate real-time predictions into ICU dashboards, reducing cognitive load and alarm fatigue¹⁸.
Explainable AI (XAI) plays a critical role in clinician acceptance. Only a minority of reviewed mortality prediction models included explainability mechanisms such as feature importance or local interpretable model-agnostic explanations¹⁰.

Figure 1 : Workflow of Artificial intelligence in ICU

Figure 2 : Overview of AI integration in ICU Care

This figures demonstrates how patient data from multiple sources, including vital signs, laboratory investigations and health records are processed using AI algorithms. The analyzed data provides real-time insights and predictive outputs that support clinicians in making timely and informed decisions in critical care settings.

Table 1 : Key applications of AI in ICU

CHALLENGES ON  IMPLEMENTATION OF AI IN ICU

While Artificial Intelligence (AI) holds great promise for improving ICU outcomes, it is not without challenges. Real-world implementation of AI in such high-stakes environments requires thoughtful navigation through technical, ethical, and practical concerns. Understanding these barriers is key to ensuring that AI becomes a reliable partner rather than a source of confusion or risk in critical care settings.

One of the biggest hurdles is data quality and availability. ICUs generate massive amounts of data every second, but the information is often scattered across different systems, incomplete, or not standardized. Many hospitals use different Electronic Health Record (EHR) platforms, making it difficult for AI models to access or interpret data consistently. Inaccurate or inconsistent data can result in misleading predictions or overlooked complications, which can be dangerous in an ICU environment³⁰.

Bias in AI models is another major concern. An AI system may not function well across various patient populations if the training data is not representative or diversified. For instance, an AI model trained predominantly on data from adult ICU patients in high-income countries might not work effectively in pediatric units or in resource-limited settings. This can lead to disparities in care and unintended harm, especially for  vulnerable groups³¹.

Then  the issue in lack of interpretability, many AI models, particularly deep learning systems, are considered “black boxes” because it's hard to explain how they arrive at a particular decision. This lack of transparency can make clinicians hesitant to trust or use AI especially when human lives are at stake. Trust is built not just on performance, but also on understanding, and must be able to justify their suggestions in a way that makes sense to healthcare providers³².

Ethical and legal considerations also play a major role. Protecting patient data privacy is essential, as AI systems often require access to large volumes of sensitive health information³³.

There is also the issue of clinician training and integration. Introducing AI into an ICU doesn’t just mean installing software, it means changing the way of care teams think, communicate, and make decisions. Doctors and nurses need to be trained to work alongside AI tools, interpret their outputs, and know when to rely on them versus when to trust their clinical judgment. If not introduced thoughtfully, AI can add to clinician burden instead of relieving it³⁴.

Overcoming these challenges requires a collaborative approach. Developers, clinicians, ethicists, and policymakers must work together to design AI tools that are accurate, fair, transparent, and easy to use. Only then we can unlock the full potential of AI in improving patient outcomes in critical care³⁵.

FUTURE RECOMMENDATIONS

A successfully integrated AI in ICUs need a multipronged strategy is essential. First, hospitals and developers should prioritize data standardization and interoperability across Electronic Health Record (EHR) systems. Standard formats like HL21 FHIR (Fast Healthcare Interoperability Resources) can facilitate smoother AI deployment across different hospital systems¹⁹.

Second, to address bias in AI models, training datasets must be diverse, inclusive, and representative of multiple patient populations—including pediatric, geriatric, and resource-limited environments. Researchers should adopt fairness auditing practices during model development²⁰.

Third, enhancing explainability is crucial. Incorporating Explainable AI (XAI) techniques, such as SHAP (Shapley Additive Explanations) or LIME (Local Interpretable Model-Agnostic Explanations), can increase clinician trust and transparency²¹^,²².

Fourth, the development of clinical-grade AI should adhere to rigorous validation, including multicenter external validation, before widespread deployment. This reduces overfitting and enhances generalizability²³.

Fifth, incorporating AI ethics and human factors into ICU workflows is vital. Interdisciplinary AI ethics committees can help monitor usage, outcomes, and adherence to principles of beneficence, non-maleficence, and justice²⁴.

Additionally, policy development is necessary to clearly delineate accountability. Regulatory frameworks like the European Union’s AI Act and guidance from FDA (USA) are evolving to address liability and patient safety²⁵.

Another key aspect is clinician training. AI literacy should become a part of medical education and ongoing professional development to ensure that providers can interpret AI outputs and identify when human override is needed²⁶^,²⁷.

Moreover, patient-centric AI development must be encouraged. Engaging ICU patients' families or patient advocates in tool development ensures alignment with values such as autonomy and shared decision-making²⁸.

Finally, real-time feedback loops where clinicians can report discrepancies between AI recommendations and clinical judgment should be established to improve continuous learning and refinement of AI models²⁹.

By following these recommendations, the implementation of AI in ICUs can become safer, more effective, and ethically sound—maximizing benefit to critically ill patients.

CONCLUSION

Artificial Intelligence (AI) is rapidly transforming the landscape of intensive care medicine. By enabling early detection of clinical deterioration, optimizing ventilator settings, supporting individualized drug dosing, and improving overall workflow, AI has the potential to enhance both patient outcomes and healthcare efficiency in ICU.

Despite these promising developments, real-world integration of AI faces several roadblocks—including limited generalizability of models, ethical concerns, lack of interpretability, and resistance from end-users. Most current tools are still in early stages of validation, and their widespread adoption demands further evidence from prospective studies and multicenter trials.

Looking ahead, the success of AI in critical care will depend on collaborative efforts between clinicians, data scientists, engineers, and policymakers. Emphasis must be placed on transparency, equity, and patient safety, with AI tools designed to complement—not replace—clinical expertise.

By investing in robust infrastructure, multidisciplinary education, and ethical governance, the future of AI in ICU care can move from experimental innovation to a trusted, integral component of critical care delivery.

REFERENCES

1.  Barboi C, Tzavelis A, Muhammad LN. Comparison of severity of illness scores and artificial intelligence models predictive of ICU mortality: meta-analysis and literature review. JMIR Med Inform. 22;23(24),e25.
2. Olang O, Mohseni S, Shahabinezhad A et.al, Artificial intelligence-based models for prediction of mortality in ICU patients: a scoping review. J Intensive Care Med. 26.
3. Diep Nguyen D, Ngo B, vanSonnenberg E. AI in the intensive care unit: up-to-date review. J Intensive Care Med. 27;28(23),29–14.
4. Suresh V, Singh KK, Vaish E, Gurjar M, Nambi AA, Khulbe Y, et al. Artificial Intelligence in the Intensive Care Unit: Current Evidence on an Inevitable Future Tool. Cureus. 26;7(24).e30.
5. Saqib M, Younas A, Mahboob A, et.al, Artificial intelligence in critical illness and its impact on patient care: a comprehensive review. Front Med (Lausanne). 31;23:32.
6. Lin TH, Lin CM, Lin YT, et.al, AI-CDSS early sepsis detection via CBC + DIFF LightGBM model. J Med Internet Res. 33;34:e35.
7. Biesheuvel LA, Bakker J, van der Horst ICC. Artificial intelligence to advance acute and intensive care medicine. Curr Opin Crit Care. 26;15(3):36–37.
8. Komorowski M, Celi LA, Badawi O, Gordon AC, Faisal AA. The Artificial Intelligence Clinician learns optimal treatment strategies for sepsis in intensive care. Nat Med. 38;39(40):41–42.
9. Johnson AEW, Pollard TJ, Shen L, et.al, MIMIC-IV, a freely accessible electronic health record dataset. Sci Data. 43;21(1):44..
10. Shickel B, Tighe PJ, Bihorac A, Rashidi P. DeepSOFA: A continuous acuity score using interpretable deep learning for critically ill patients. Nat Commun. 45;23(1):1–23.
11. Shashikumar SP, Stanley MD, Sadiq I, et.al, Early sepsis detection using novel recurrent neural survival models. Front Digit Health. 27;3:46.
12. Vincent JL, Moreno R, Takala J, et.al, The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Med. 47;48(21):49–23.
13. Pinsky MR, Clermont G, Kalb T. Predicting ICU outcomes using physiologic data and machine learning. Crit Care. 31;34(1):50.
14. Schmid M, Zick G, Pulletz S, et.al, Electrical impedance tomography for individualized ventilation therapy in ARDS. Crit Care. 27;51:52. PMID:53.
15.  Herasevich V, Kor DJ, Subramanian A, Pickering BW. Connecting the dots: rule-based decision support systems in the modern EMR era. J Clin Monit Comput. 54;34(11):55–56.
16. Kim J, Ling L, Zhao Z. Practical applications of artificial intelligence in intensive care units. J Intensive Care Med. 31;57(1):14–16.
17. Evans RS, Pestotnik SL, Classen DC, et.al, A computer-assisted management program for antibiotics and other antiinfective agents. N Engl J Med.58;59(11):60–57.
18. Vincent JL, Opal SM, Marshall JC, Tracey KJ. Sepsis definitions: time for change. Lancet. 54;61(62):63–64.
19. Caruana R, Lou Y, Gehrke J, et.al, Intelligible models for healthcare: Predicting pneumonia risk and hospital admission outcomes. Proc KDD. 65;66–15.
20. Topol EJ. High-performance medicine: the convergence of human and artificial intelligence. Nat Med. 45;51(1):67–68.
21. Vincent JL, de Mendonça A, Cantraine F, et.al, Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units. Crit Care Med. 58;69(40):70–71.
22. Zeiberg D, Prahlad T, Desai A, et.al, Machine learning for real-time prediction of complications in critical care: a systematic review. Crit Care Explor. 22;11(72):e73.
23. Nguyen M, Keogh RH, van der Schaar M. Machine learning in critical care: challenges and opportunities. Curr Opin Crit Care. 31;74(1):1–13.
24. Pinsky MR, Vincent JL. Data integration and visualization for critical care medicine. J Crit Care. 27;75:76–67.
25. Mehta AB, Cooke CR. Machine learning in ICU decision-making: ethical considerations and frameworks. Chest. 27;77(24):78–79.
26.  Esteva A, Robicquet A, Ramsundar B, et.al, A guide to deep learning in healthcare. Nat Med. 45;51(1):39–74.
27. Sendak MP, Ratliff W, Sarro D, et.al, Real-world integration of a sepsis deep learning technology into routine clinical care: implementation study. JMIR Med Inform. 43;13(21):e80. PMID:81.
28. Obermeyer Z, Powers B, Vogeli C, Mullainathan S. Dissecting racial bias in an algorithm used to manage the health of populations. Science. 45;82(83):84–85.
29. London AJ. Artificial intelligence and black-box medical decisions: accuracy versus explainability. Hastings Cent Rep. 45;86(1):87–88.
30. Chen IY, Joshi S, Ghassemi M. Treating health disparities with artificial intelligence. Nat Med. 43;69(1):7–89.
31. Wiens J, Saria S, Sendak M, et.al, Do no harm: a roadmap for responsible machine learning for health care. Nat Med. 45;51(72):90–18.
32. Lin TH et al. Automated documentation in ICU using AI: early evaluation of clinician time savings. J Med Syst. 26;56(1):e91.
33. Zhang Z, Cava W, Sayre M, et.al, Machine learning methods for predicting patient outcomes in ICU: a comparison study. Comput Methods Programs Biomed. 43;92:93.
34.  Vellido A. Societal issues concerning the application of artificial intelligence in medicine. Kidney Dis (Basel). 45;24(1):40–89.
35. Celi LA, Fine B, Stone DJ. An awakening in medicine: the partnership of humanity and intelligent machines. Lancet Digit Health. 45;1(19):e94–95.
36. Dilsizian SE, Siegel EL. Artificial intelligence in medicine and cardiac imaging: harnessing big data and advanced computing to provide personalized medical diagnosis and treatment. Curr Cardiol Rep. 96;7(1):97.
37. Shaw J, Rudzicz F, Jamieson T, Goldfarb A. Artificial intelligence and the implementation challenge. J Med Internet Res. 45;88(21):e98.
38. Jha S, Topol EJ. Adapting to artificial intelligence: radiologists and pathologists as information specialists. JAMA. 99;100(48):101–102.
39. Yu KH, Beam AL, Kohane IS. Artificial intelligence in healthcare. Nat Biomed Eng. 38;2(23):103–16.
40. Rajpurkar P, Chen E, Banerjee O, Topol EJ. AI in health and medicine. Nat Med. 22;104(1):16–57.